2024-12-22 12:50:47
First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
Health/ 2023-10-08
First patient treated with Cu-67 SAR-Bom...

SYDNEY,Oct. 3,2023-- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"),a clinical-stage radiopharmaceutical company with a mission to...

FDA Grants Transcenta Clearance to Proceed with Global Phase III Trial of Osemitamab (TST001) as First-Line Treatment for Gastric/Gastroesophageal Cancer Patients
Health/ 2023-10-08
FDA Grants Transcenta Clearance to Proce...

Osemitamab (TST001) on Track to Become a Global Therapy that Elevates the Current Standard of Care for HER2-Negative G/GEJ Adenocarcinoma

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release